Corcept Therapeutics (NASDAQ:CORT) Shares Gap Up Following Analyst Upgrade
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) shares gapped up before the market opened on Monday after Canaccord Genuity Group raised their price target on the stock from $130.00 to $142.00. The stock had previously closed at $54.63, but opened at $94.93. Canaccord Genuity Group currently has a buy rating on the stock. Corcept […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) shares gapped up before the market opened on Monday after Canaccord Genuity Group raised their price target on the stock from $130.00 to $142.00. The stock had previously closed at $54.63, but opened at $94.93. Canaccord Genuity Group currently has a buy rating on the stock. Corcept […]
